NovaBay Pharmaceuticals, Inc. - FORM 10-K - EX-23.1 - EXHIBIT 23.1 - March 23, 2017

Attached files

file filename
10-K - FORM 10-K - NovaBay Pharmaceuticals, Inc.nby20161231_10k.htm
EX-32.2 - EXHIBIT 32.2 - NovaBay Pharmaceuticals, Inc.ex32-2.htm
EX-32.1 - EXHIBIT 32.1 - NovaBay Pharmaceuticals, Inc.ex32-1.htm
EX-31.2 - EXHIBIT 31.2 - NovaBay Pharmaceuticals, Inc.ex31-2.htm
EX-31.1 - EXHIBIT 31.1 - NovaBay Pharmaceuticals, Inc.ex31-1.htm
EX-10.7 - EXHIBIT 10.7 - NovaBay Pharmaceuticals, Inc.ex10-7.htm
EX-4.5 - EXHIBIT 4.5 - NovaBay Pharmaceuticals, Inc.ex4-5.htm
EX-4.3 - EXHIBIT 4.3 - NovaBay Pharmaceuticals, Inc.ex4-3.htm
EX-4.2 - EXHIBIT 4.2 - NovaBay Pharmaceuticals, Inc.ex4-2.htm
EX-4.1 - EXHIBIT 4.1 - NovaBay Pharmaceuticals, Inc.ex4-1.htm

Exhibit 23.1

 

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

We hereby consent to the incorporation by reference in Registration Statements on Form S-8 (File Nos. 333-215680, 333-211754, 333-208985, 333-203109, 333-196764, 333-194383, 333-185998, 333-180461, 333-171981, 333-147334, 333-157041, and 333-164469) and Form S-3 (File Nos. 333-211944, 333-211943 333-204998, 333-203735, 333-203112, 333-159917 and 333-180460) of NovaBay Pharmaceuticals, Inc. of our report dated March 23, 2017, relating to the consolidated financial statements of NovaBay Pharmaceuticals, Inc., which appears in this Annual Report on Form 10-K.

 

/s/ OUM & CO. LLP

 

San Francisco, California

March 23, 2017

NovaBay Pharmaceuticals, Inc. Reports